A complete guide to wernickes encephalopathy and korsakoff’s psychosis

Reading File
Now I'll run parallel searches across headings and paragraphs for both conditions, plus a PubMed search and web search simultaneously.
Finding Sources
Finding Sources
Searching PubMed

"Wernicke encephalopathy"[MeSH Terms] AND "thiamine"[MeSH Terms]

Searching the Web

Wernicke encephalopathy Korsakoff psychosis clinical guide 2024 2025

Now let me read the most comprehensive textbook sections in parallel:
Reading File
Reading File
Reading File
Finding Sources
Excellent. Now let me read the Goldman-Cecil Korsakoff section, Adams & Victor section, and Maudsley treatment dosing in parallel:
Reading File
Reading File
Reading File
Finding Sources
Now let me get the MRI imaging, Robbins pathology section, and Bradley's full WE section for completeness:
Reading File
Reading File
Reading File
Searching Images

Wernicke encephalopathy MRI brain mammillary bodies thalamus

I now have comprehensive data from multiple authoritative sources. Let me compile the complete guide.

Wernicke's Encephalopathy & Korsakoff's Psychosis: A Complete Guide

1. Overview & Historical Context

Wernicke's encephalopathy (WE) and Korsakoff's syndrome (KS) represent two ends of a single disease spectrum — Wernicke-Korsakoff syndrome (WKS) — both caused by thiamine (vitamin B1) deficiency. WE is the acute, potentially reversible phase; KS is the chronic, largely irreversible amnestic state that follows.
  • WE was first described by Gayet (French ophthalmologist) in 1875, and independently by Carl Wernicke (German neurologist) in 1881.
  • "Korsakoff psychosis" is an older term; modern neurology prefers Korsakoff syndrome or amnesic state, as psychosis is not the dominant feature. — Adams and Victor's Principles of Neurology, 12th ed.

2. Thiamine Biochemistry & Pathophysiology

Thiamine (B1), as thiamine pyrophosphate (TPP), is a critical cofactor in energy metabolism:
  • Pyruvate dehydrogenase — entry into the TCA cycle
  • α-ketoglutarate dehydrogenase — TCA cycle intermediate step
  • Transketolase — pentose phosphate pathway
Deficiency of α-ketoglutarate dehydrogenase activity in astrocytes leads to microglial activation and glutamatergic toxicity, the key mechanism of WE neuronal injury. — Goldman-Cecil Medicine
Because thiamine is required to metabolize glucose, administration of IV glucose before thiamine replacement can precipitate or worsen WE — a critical clinical pitfall. — Maudsley Prescribing Guidelines, 15th ed.
Total body thiamine stores are depleted within 2–3 weeks of inadequate intake.

3. Causes & Risk Factors

Primary Cause

  • Chronic alcohol use disorder — the most common cause in Western countries (both reduced dietary intake and impaired intestinal absorption)

Non-alcoholic Causes

CategoryExamples
Prolonged vomitingHyperemesis gravidarum, cyclical vomiting, chemotherapy
MalabsorptionBariatric surgery (especially gastric bypass), inflammatory bowel disease
Refeeding syndromesParenteral nutrition without thiamine supplementation
Systemic illnessAIDS/HIV, cancer, cachexia
DialysisThiamine lost during hemodialysis (33% prevalence of deficiency in symptomatic dialysis patients) — Bradley & Daroff's Neurology
Eating disordersAnorexia nervosa, bulimia nervosa
Prolonged fastingHunger strikes, extreme diets
Digitalis poisoning

Risk Factors in Alcohol Dependence (Maudsley Guidelines)

  • Acute withdrawal
  • Malnourishment / low BMI (<18)
  • Decompensated liver disease
  • Emergency department attendance or acute hospitalization
  • Homelessness
  • Memory disturbance or peripheral neuropathy
  • Previous episode of WE

4. Neuropathology

Affected Brain Regions

WE preferentially affects regions with the highest thiamine-dependent metabolic demand:
  • Mammillary bodies (most characteristic; bilaterally affected)
  • Periaqueductal gray matter
  • Medial thalami (anterior and centromedian nuclei; dorsomedial thalamic nucleus lesions best correlate with memory disturbance in KS)
  • Floor of the fourth ventricle
  • Superior and inferior colliculi
  • Hypothalamus (occasionally)
  • Cerebral cortex (rarely, in severe cases)

Microscopic Changes

  • Neuronal swelling and microscopic hemorrhages (early)
  • Gliosis (later)
  • Resolution of necrosis → cystic spaces with hemosiderin-laden macrophages
In Korsakoff syndrome, damage is concentrated in the limbic system: mammillary bodies, amygdala, dorsomedial thalamus, and anterior thalamus. Cortical involvement in KS may relate to direct alcohol neurotoxicity rather than thiamine deficiency per se. — Robbins & Kumar Basic Pathology; Goldman-Cecil Medicine

5. Clinical Presentation

Wernicke's Encephalopathy: Classic Triad

FeatureDescription
Mental status changesRanges from mild inattention and memory impairment to delirium and coma; often with apathy or abulia
Ocular abnormalitiesNystagmus, dysconjugate gaze, horizontal/vertical gaze palsies, ophthalmoplegia
AtaxiaAffects legs > arms > trunk; gait ataxia prominent
⚠️ The full triad is present in only ~30% of cases. Up to 75% of cases are undiagnosed at the time of death (only ~25% detected before death). — Goldman-Cecil Medicine

Additional Features

  • Autonomic dysfunction: bradycardia, hypothermia, hypotension (can be life-threatening)
  • Papilledema, optic neuropathy
  • Seizures, myoclonus
  • Peripheral neuropathy
  • Signs of chronic alcoholism (gynecomastia, palmar erythema, Dupuytren's contractures, ascites)

Maudsley Guidance: Presume WE in Any Detoxification Patient with ANY of:

  • Ataxia
  • Hypothermia or hypotension
  • Confusion or memory disturbance
  • Ophthalmoplegia / nystagmus
  • Unconsciousness / coma

6. Korsakoff's Syndrome

Core Features

Korsakoff syndrome develops in up to 80% of patients surviving WE. It is more likely to follow WE in the setting of alcoholism than in pure nutritional deficiency — likely due to synergistic mechanisms including repeated alcohol withdrawal causing glutamate neurotoxicity compounded by thiamine deficiency. — Goldman-Cecil Medicine
Three cardinal features (Adams & Victor):
  1. Retrograde amnesia — impaired recall of events established before onset
  2. Anterograde amnesia — inability to form new memories or learn new information
  3. Impaired temporal localization of past experience

What Is Preserved

  • Alertness and attention
  • Language comprehension and expression
  • Spatial organization
  • Procedural (motor) memory
  • Immediate recall (digit span) — a measure of registration/attention, not memory encoding
  • Social interaction
"Equally important in the definition of the Korsakoff syndrome is this integrity of certain aspects of behavior and mental function." — Adams & Victor's Principles of Neurology

Confabulation

  • Momentary confabulation: partial memories inaccurately localized in time, provoked by questions
  • Fantastic confabulation: spontaneous elaborate false narratives; more common in the initial confused phase
  • Confabulation is not obligate for diagnosis; it typically lessens over time as a compensatory mechanism — Adams & Victor

Neuropsychological Profile

  • Anterograde > retrograde amnesia severity
  • Remote (early life) memories relatively preserved vs. recent (Ribot's Rule)
  • Mild executive dysfunction (frontal lobe involvement)
  • Patients are typically unaware of their memory impairment (anosognosia)

7. Neuroimaging

MRI Findings in Acute WE

T2-weighted/FLAIR sequences show bilateral and symmetrical hyperintensities in:
  • Mammillary bodies
  • Periaqueductal gray matter
  • Medial thalami / periventricular regions of the 3rd ventricle
  • Floor of the 4th ventricle / pons / medulla
  • Basal ganglia (less commonly)
  • Cortex (rare; implies severe disease)
Wernicke encephalopathy DWI MRI showing bilateral hyperintensities in medial thalamus and mammillary bodies
DWI MRI showing bilateral symmetric hyperintensities in medial thalamus (arrows) and mammillary bodies — classic hallmarks of Wernicke encephalopathy
FLAIR MRI Wernicke encephalopathy with labeled mammillary bodies, colliculi, periventricular regions, thalamus
FLAIR MRI series: bilateral symmetric hyperintensities in periventricular gray matter (3rd ventricle walls), fornix, mammillary bodies, colliculi, and medial thalami

Special MRI Findings

  • DWI: restricted diffusion (cytotoxic edema); may show vasogenic component (increased ADC)
  • Microbleeds on T1/GRE in thalami and mammillary bodies → poor outcome marker
  • Contrast enhancement of mammillary bodies: present in ~80% of cases, even before T2 changes are visible — considered highly specific — Grainger & Allison's Diagnostic Radiology
  • Periaqueductal contrast enhancement: ~50% of cases

MRI in Chronic Korsakoff Syndrome

  • T2 signal changes become less prominent
  • Diffuse brain atrophy, most pronounced in the mesencephalon and mammillary bodies
MRI can be normal in symptomatic WE — a normal MRI does not exclude the diagnosis.

8. Laboratory Investigations

TestFinding
Serum thiamineLow (<50 nmol/L); may be normal in ~10%
RBC transketolase activityReduced (most sensitive functional test)
Serum lactate & pyruvateElevated (disrupted carbohydrate metabolism)
MCV, LFTs, GGTSigns of chronic alcohol use
MagnesiumOften deficient; critical to replace (required for thiamine utilization)
SodiumMay be low; must be replaced carefully

9. Diagnosis

WE is a clinical diagnosis — do not wait for labs or MRI before treating.
The Caine criteria (operational diagnostic criteria used in clinical practice) require any 2 of:
  1. Dietary deficiency
  2. Oculomotor abnormalities
  3. Cerebellar dysfunction
  4. Either altered mental status or mild memory impairment
A presumptive diagnosis should be made in any at-risk patient with even a single feature.

Differential Diagnoses to Consider

  • Hepatic encephalopathy
  • Delirium tremens (overlapping with acute alcohol withdrawal)
  • Meningitis/encephalitis
  • Posterior reversible encephalopathy syndrome (PRES)
  • Central pontine myelinolysis
  • Drug intoxication / overdose
  • Stroke (thalamic, brainstem)

10. Treatment

Principle: Treat First, Confirm Later

"In acute settings, especially in ICUs, all patients should receive replenishment with high-dose IV or IM thiamine prior to any glucose administration." — Goldman-Cecil Medicine

Thiamine Replacement Doses

If WE is suspected / confirmed (acute treatment):
  • IV or IM thiamine 500–1000 mg/day × 3–5 days — Goldman-Cecil Medicine
  • UK NICE / Maudsley Guidelines: IV thiamine (Pabrinex) 2–3 pairs (each pair = 250 mg) three times daily for 3–5 days
Prophylaxis in high-risk patients (e.g., alcohol detoxification):
  • Community: IM thiamine 200–300 mg once daily for at least 3 days
  • Hospital: IM or IV thiamine 200–300 mg once daily for 3–5 days with daily monitoring
Low-risk drinkers with adequate diet:
  • Oral thiamine 300 mg daily during withdrawal

Additional Measures

  • Never give IV glucose before thiamine in a thiamine-deficient or at-risk patient
  • Replace magnesium (required cofactor for thiamine-dependent enzymes)
  • Replace sodium if deficient
  • Monitor electrolytes, fluid balance
  • Treat nausea/vomiting (metoclopramide 10 mg or prochlorperazine 5 mg)

Response to Treatment

  • Nystagmus and ophthalmoplegia resolve first — often within hours of thiamine administration
  • Ataxia resolves more slowly (days to weeks)
  • Mental status changes — variable; may partially or fully resolve
  • Korsakoff syndrome does not respond to thiamine replacement — prevention by early recognition of WE is essential

11. Prevention

  • Thiamine supplementation of anyone at risk due to vomiting, starvation, bariatric surgery, dialysis, or malnutrition (>100 mg/day)
  • Routine thiamine fortification of foods (e.g., flour, rice) has reduced the population burden
  • Universal thiamine before IV dextrose in the emergency department for at-risk patients
  • Post-bariatric surgery: lifelong thiamine supplementation is standard of care

12. Prognosis

OutcomeData
WE untreated mortality~90%
WE treated mortalityUp to 20%
KS following WE~80% of WE survivors
KS long-term mortality~50% of treated patients die within 8 years
Cognitive function in KSStable (neither progressive nor recovering)
Residual deficitsAtaxia and cognitive/memory impairment (partly from alcohol neurotoxicity)
"Because Korsakoff syndrome does not respond to thiamine replacement, prevention by timely recognition of Wernicke encephalopathy is essential." — Goldman-Cecil Medicine

Recovery from KS

A small proportion (< 20%) achieve partial recovery with prolonged abstinence from alcohol, but full recovery is rare. Prognosis is better in non-alcoholic WKS (e.g., hyperemesis gravidarum).

13. Special Populations

Pregnancy (Hyperemesis Gravidarum)

WE complicating hyperemesis gravidarum is a well-described, systematically reviewed entity. High index of suspicion required; thiamine must be given before IV dextrose. Fetal brain injury is possible if untreated.

Bariatric Surgery

A leading non-alcoholic cause. ASMBS published dedicated clinical guidelines (2025) on prevention, diagnosis and treatment of WE/WKS in bariatric patients.

Renal Failure / Dialysis

Thiamine is water-soluble and dialyzable; patients on renal replacement therapy have high rates of deficiency. A 2024 systematic review (PMID 37838073) documented this in both acute and chronic kidney disease. Routine supplementation is indicated.

HIV/AIDS & Cancer

Cachexia, malabsorption, and poor oral intake create risk. WE can occur without any alcohol history.

14. Comparison: WE vs. KS

FeatureWernicke's EncephalopathyKorsakoff's Syndrome
PhaseAcuteChronic
MechanismActive thiamine deficiencyStructural limbic/thalamic damage
Core featuresConfusion, ophthalmoplegia, ataxiaAnterograde + retrograde amnesia, confabulation
ConsciousnessImpaired (delirium → coma)Preserved (patient is alert)
ReversibilityYes — if treated promptlyLargely irreversible
Response to thiamineDramatic (oculomotor signs first)No significant response
MRIActive edema/hemorrhage in mammillary bodies, thalami, periaqueductalAtrophy of mammillary bodies, mesencephalon
ConfabulationNot typicalPresent (especially early phase)

15. Key Takeaways for Clinical Practice

  1. Diagnose clinically — do not wait for lab confirmation or MRI to start thiamine.
  2. The full classic triad is present in <30% of cases — treat on suspicion.
  3. Never administer IV glucose before thiamine in any malnourished or alcohol-dependent patient.
  4. High-dose IV thiamine (500–1000 mg/day for 3–5 days) is the standard for suspected WE.
  5. Magnesium replacement is mandatory alongside thiamine.
  6. Korsakoff syndrome is preventable but not treatable — early WE recognition is the only strategy.
  7. Non-alcoholic WE is common — think bariatric surgery, hyperemesis, cancer, dialysis.
  8. Only 25% of WE cases are detected before death — the syndrome is massively under-recognized.

Sources

  • Goldman-Cecil Medicine, International Edition
  • Adams and Victor's Principles of Neurology, 12th Edition
  • Maudsley Prescribing Guidelines in Psychiatry, 15th Edition
  • Grainger & Allison's Diagnostic Radiology
  • Robbins & Kumar Basic Pathology
  • Bradley and Daroff's Neurology in Clinical Practice
  • Recent systematic reviews: PMID 37322816 (WE in hyperemesis gravidarum, 2023), PMID 37838073 (WE in kidney disease, 2024), PMID 38306946 (diagnosis and treatment systematic review, 2024)
This is a shared conversation. Sign in to Orris to start your own chat.